RT Journal Article
SR Electronic
T1 Identifying Synergistic Interventions to Address COVID-19 Using a Large Scale Agent-Based Model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.11.20247825
DO 10.1101/2020.12.11.20247825
A1 Junjiang Li
A1 Philippe J. Giabbanelli
YR 2020
UL http://medrxiv.org/content/early/2020/12/14/2020.12.11.20247825.abstract
AB There is a range of public health tools and interventions to address the global pandemic of COVID-19. Although it is essential for public health efforts to comprehensively identify which interventions have the largest impact on preventing new cases, most of the modeling studies that support such decision-making efforts have only considered a very small set of interventions. In addition, previous studies predominantly considered interventions as independent or examined a single scenario in which every possible intervention was applied. Reality has been more nuanced, as a subset of all possible interventions may be in effect for a given time period, in a given place. In this paper, we use cloud-based simulations and a previously published Agent-Based Model of COVID-19 (Covasim) to measure the individual and interacting contribution of interventions on reducing new infections in the US over 6 months. Simulated interventions include face masks, working remotely, stay-at-home orders, testing, contact tracing, and quarantining. Through a factorial design of experiments, we find that mask wearing together with transitioning to remote work/schooling has the largest impact. Having sufficient capacity to immediately and effectively perform contact tracing has a smaller contribution, primarily via interacting effects.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors thank the Microsoft AI for Health program for supporting this research effort through a philanthropic grant.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study uses secondary data and models, hence it is exempt from IRB or ethics committee approvals.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOur work is based on the Covasim model, which is open source and can be accessed without registration. Table 2 lists all parameters used in this study and tracks their provenance.